Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/120521
Title: CHARACTERIZATION OF DENGUE NEUTRALIZING ANTIBODIES USING RECOMBINANT ANTIBODIES TECHNOLOGY
Authors: XU MEIHUI
Keywords: Dengue, human, plasmablast, neutralizing antibody, antibody engineering, epitope mapping
Issue Date: 23-Jan-2015
Citation: XU MEIHUI (2015-01-23). CHARACTERIZATION OF DENGUE NEUTRALIZING ANTIBODIES USING RECOMBINANT ANTIBODIES TECHNOLOGY. ScholarBank@NUS Repository.
Abstract: IN THE LATE 1700S, EDWARD JENNER DESCRIBED INDUCED IMMUNITY IN WHICH HE DEMONSTRATED THAT INOCULATION WITH COWPOX PREVENTED ONE FROM DEVELOPING DISEASE AGAINST SMALLPOX. A CENTURY LATER, EMIL ADOLF VON BEHRING EXPLORED THE POTENTIAL OF PASSIVE IMMUNITY AS AN ANTI-TOXIN THERAPY AGAINST TETANUS. THESE PIONEER WORKS LAID THE CORNERSTONES FOR SUBSEQUENT VACCINE AND THERAPEUTIC ANTIBODY DEVELOPMENT AS WELL AS FOR TODAY?S EXPLODING IMMUNOTHERAPY RESEARCH. THE FIRST HALF OF THIS THESIS IS DEDICATED TO THE CLONING, EXPRESSION, AND CHARACTERIZATION OF MONOCLONAL ANTIBODIES OBTAINED FROM TWO NATURALLY INFECTED DENGUE PATIENTS. THIS LED TO THE SUBSEQUENT DISCOVERY AND FURTHER CHARACTERIZATION OF AN ANTIBODY THAT POSSESSES POTENT NEUTRALIZATION CAPACITY AGAINST ALL FOUR DENGUE VIRUS SEROTYPES. IN PARALLEL, AN ATTEMPT TO DESIGN ANTIBODIES THAT CAN CROSS-NEUTRALIZE ALL FOUR DENGUE VIRUS SEROTYPES BY AN ENGINEERING APPROACH WAS MADE AND WILL BE DESCRIBED IN THE SECOND HALF OF THIS THESIS. THIS THESIS
URI: http://scholarbank.nus.edu.sg/handle/10635/120521
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
XuMH.pdf10.09 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

132
checked on Sep 19, 2020

Download(s)

60
checked on Sep 19, 2020

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.